NewGenIvf Group Limited Stock Pattern Recognition Two Crows
| NIVF Stock | 0.50 0.0001 0.02% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of forty-nine. The function did not return any valid pattern recognition events for the selected time horizon. Two Crows is a 3-day pattern that warns about a possible future trend reversal for NewGenIvf Group.
NewGenIvf Group Technical Analysis Modules
Most technical analysis of NewGenIvf Group help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NewGenIvf from various momentum indicators to cycle indicators. When you analyze NewGenIvf charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
NewGenIvf Group participates in national exchange markets. This overview emphasizes how NewGenIvf Group compares to peers on valuation quality and operating consistency. Current metrics include P/B of 0.02, profit margin of 3.81%. NewGenIvf Group has a market cap of 506.33 K, ROE of 1.61%.
Methodology
Unless otherwise specified, financial data for NewGenIvf Group Limited is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. NewGenIvf (USA Stocks:NIVF) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Underlying inputs rely on public filings and market reference sources, including disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Values may reflect publication timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
NewGenIvf Group Limited may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardAlign your values with your investing style
Using NewGenIvf Group Limited inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Corona Opportunity Invested few shares | |
 | Warren Buffett Holdings Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Social Domain Invested few shares | |
 | Driverless Cars Invested few shares | |
 | ESG Investing Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | FinTech Invested over 20 shares | |
 | Video Games Invested few shares |
More Resources for NewGenIvf Stock Analysis
A structured review of NewGenIvf Group often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Key reports that frame NewGenIvf Group Limited Stock are listed below:NewGenIvf Group has a market cap of 506.33 K, operating margin of -1.96%, ROE of 1.61%. Correlation Analysis can help frame allocation decisions. The allocation includes a position in NewGenIvf Group Limited in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. Analysis related to NewGenIvf Group should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Earnings Share 4.2 K | Revenue Per Share | Quarterly Revenue Growth -0.13 | Return On Assets | Return On Equity |
Market capitalization and book value offer complementary views of NewGenIvf Group — the first driven by investor sentiment, the second by accounting standards. NewGenIvf Group's market capitalization is 506.33 K. A P/B ratio of 0.02 suggests NewGenIvf Group trades near or below book value. Enterprise value stands at 5.71 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Value and price for NewGenIvf Group are related but not identical, and they can diverge across cycles. For NewGenIvf Group, key inputs include a P/B ratio of 0.02, a profit margin of 3.81%, ROE of 1.61%, and revenue of 5.43 M. Trading price represents the transaction level agreed by market participants.